# pathway_0179: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0179.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | no saved label | no saved label | output error (invalid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSHSSHYSPVDSGMVPSSSSTEDHLSPTLSASIVLPAQLNPFAKAYDIPPSSIVQLGWALLLRCHLAIPSPCWSTIDDKTMPRGSDTHALQWESLHLEEGRSISWILQRWEDPSVHWYLSSDQLPGSKSPTLTTMLFLVKEYGLFDPVTPIDPGMGTIIYFYPSDEQPRLHISWNPDVVSSGHAFHLTRSLEHALQTIFLAPSVDIRDVNLFGIWDHQQLLQWNSYCPDPVDRLVQEMFQDVVAATPEASAVAAWDGELNYRELDRLSSRLAGVLQSDFGVVSETIVALCFEKSVWAIVAMLAVVKAGGAFLHIDPQHPPARHQAMIKSTASKLFLCSEQTRDTVVRSVPDCPSLVIHREMFAAQPDHAQQDTVISSGNLGPTNAAYVVCTSGSTGTPKAIVVEHVSLCSSVTAQAKAMDITAGSRVLQYAAYTFDVSIGDIFAALTHGACICIPSNWERAHDLSGAINRLGVNQACLTSTVASLLTPVEVPKLKKLTLGGEPATQQCINMWVDKVALKNIYGPAECTVWCIIQPDVSSGIAVSNIGHAIGARAWIVHPENHDRLMPIGAVGELLIEGPLVARGYLNDPVRTNAVFLAQPPIWLASFGPPPPRSRFYKTGDLARYGPGGALLFEGRKDTQVKLRGQRIELGEVEYRLHQALSDLSPSAAVELVHPKESTAPLLCAFITWDEGIDLDLQPAKPPLSACLTPNARKRFNHTVSLLQTEMERTLPAYMIPGLCIPVHKLPLTTSGKLDRKALRYFCTQHSLAFLSTFENNNVNSPTDGATDSFAAPLETVSPAESTLAQLWAQVLGRKTDSIGRKDNFLSLGGDSLAAMRLVNRAARDAQLTLTVADVFKCPVLADQASLVRPLVQTRNLVPFELMAPGDLQIEDLVAYVAEKCGVLHDQVEDIYPCTPLQDEMMRDSLSGDRTQMGQEVILLAEDLDIPRYLSACARVFQRFPILRTRFVQHSDRLIQVVIRENLGWQRPESLTEYVEADAKEAPALNKPLTRWALTSDSTHCILTMHHSIFDGISLGHILGAIYAVYQSIPLPPDSVSFAAFLAQINEHTSGLSDDSKQFWRSYLRPSPGSGDLPLPIVDSTYRPCANRGTQRLVTFQSGVVPALQQHGLTEATLIRGAWACTLAQLQTSSSTPSDVVFGTILTGRNLHLPGVDALVAPTLTHAPIRIRMSAASNEKPASFLARVQADATAMIPFEHDGMDRIRAIDAQVRAVCDQMQTLLVIQPIPEGLTSASTSPFPGPILSGPRVEAREMRHFHWYGLLVECTLLPTNGFFVRMCYDDKLFSSEDVERLLDDYSQALHELGGGLTEGEEVHLPTERKLDTLTLPGLVAPSGAEDMV

[Multiple Choices]
A. Cell wall degradation
B. ubiquinone biosynthesis. .
C. Antifungal biosynthesis. .
D. Pigment biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact supplied sequence matches the UniProt entry annotated as nonribosomal peptide synthetase rstn8, with the pathway listed as antifungal biosynthesis. The pathway annotation cites PubMed 33857369 with ECO:0000269 evidence; this supports the key, though the cited study was not independently assessed here.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is consistent with a multidomain nonribosomal peptide synthetase, which supports a role in natural-product biosynthesis. That alone does not establish that its product is antifungal rather than associated with another biosynthetic pathway.


**Missing item-specific fact**

> The protein-specific identification as Rstn8 and its association with restricticin/antifungal biosynthesis, which is supplied by the database annotation and cited study, not by the question.


**Reason**

> The sequence may suggest a biosynthetic enzyme, but distinguishing antifungal biosynthesis from other natural-product options requires item-specific pathway information. Recognizing the sequence through an external database would be lookup, not reasoning from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied sequence alone does not uniquely distinguish the listed pathways, but the reviewer evidence supports C and does not establish another listed choice as an equally defensible answer.


### Important caveats

- The UniProt record and historical record match the supplied sequence; the source snapshot used by the author is unknown.
- The cited evidence supports a curated pathway annotation, but the primary paper was not independently reviewed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is consistent with a multidomain nonribosomal peptide synthetase, which supports a role in natural-product biosynthesis. That alone does not establish that its product is antifungal rather than associated with another biosynthetic pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification as Rstn8 and its association with restricticin/antifungal biosynthesis, which is supplied by the database annotation and cited study, not by the question.",
    "reason": "The sequence may suggest a biosynthetic enzyme, but distinguishing antifungal biosynthesis from other natural-product options requires item-specific pathway information. Recognizing the sequence through an external database would be lookup, not reasoning from the supplied input."
  },
  "case_id": "pathway_0179",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry annotated as nonribosomal peptide synthetase rstn8, with the pathway listed as antifungal biosynthesis. The pathway annotation cites PubMed 33857369 with ECO:0000269 evidence; this supports the key, though the cited study was not independently assessed here."
  },
  "important_caveats": [
    "The UniProt record and historical record match the supplied sequence; the source snapshot used by the author is unknown.",
    "The cited evidence supports a curated pathway annotation, but the primary paper was not independently reviewed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied sequence alone does not uniquely distinguish the listed pathways, but the reviewer evidence supports C and does not establish another listed choice as an equally defensible answer."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0179",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry annotated as nonribosomal peptide synthetase rstn8, with the pathway listed as antifungal biosynthesis. The pathway annotation cites PubMed 33857369 with ECO:0000269 evidence; this supports the key, though the cited study was not independently assessed here.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is consistent with a multidomain nonribosomal peptide synthetase, which supports a role in natural-product biosynthesis. That alone does not establish that its product is antifungal rather than associated with another biosynthetic pathway.",
    "missing_item_specific_fact": "The protein-specific identification as Rstn8 and its association with restricticin/antifungal biosynthesis, which is supplied by the database annotation and cited study, not by the question.",
    "reason": "The sequence may suggest a biosynthetic enzyme, but distinguishing antifungal biosynthesis from other natural-product options requires item-specific pathway information. Recognizing the sequence through an external database would be lookup, not reasoning from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied sequence alone does not uniquely distinguish the listed pathways, but the reviewer evidence supports C and does not establish another listed choice as an equally defensible answer."
  },
  "important_caveats": [
    "The UniProt record and historical record match the supplied sequence; the source snapshot used by the author is unknown.",
    "The cited evidence supports a curated pathway annotation, but the primary paper was not independently reviewed here."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A0L1JF11 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:33857369. The protein is a nonribosomal peptide synthetase (rstn8) in the restricticin biosynthesis gene cluster of Aspergillus nomiae, and restricticin is a natural product CYP51 inhibitor with antifungal activity. The sequence match is confirmed (SHA256 identical).

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> One can reasonably infer from the long multi-modular architecture (~1358 aa) with recognizable adenylation and condensation domain motifs that this is a nonribosomal peptide synthetase (NRPS), which effectively eliminates option A (cell wall degradation, typically glycosyl hydrolases) and option B (ubiquinone biosynthesis, typically prenyltransferases and oxidoreductases). However, NRPS enzymes produce both antifungal compounds and pigments, so the sequence alone does not distinguish option C from option D.


**Missing item-specific fact**

> Knowing that this specific NRPS (rstn8) produces restricticin, a CYP51 inhibitor with antifungal activity, rather than a pigment compound, requires knowledge of the specific biosynthetic gene cluster context and the biological activity of the final product—information not derivable from the amino acid sequence alone.


**Reason**

> While NRPS identification eliminates A and B through general domain-architecture reasoning, the distinction between 'antifungal biosynthesis' (C) and 'pigment biosynthesis' (D) depends on knowing the specific compound produced and its biological activity, which is an item-specific fact absent from the sequence input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "C",
  "D"
]
```

> Both antifungal biosynthesis and pigment biosynthesis are common NRPS-derived pathways in fungi. Without the gene cluster context or knowledge of the specific product (restricticin), a model identifying the protein as an NRPS could plausibly select either C or D. The UniProt annotation resolves this to C, but the sequence alone does not.


### Important caveats

- The UniProt pathway annotation carries experimental evidence (ECO:0000269) from a 2021 JACS paper characterizing the restricticin BGC, so the key is well-supported by primary literature.
- The protein was first publicly annotated in UniProt on 2025-02-05; if the benchmark was constructed before that date, the annotation may have come from a different source or been inferred computationally.
- The reviewer-only evidence was absent from the evaluated model input; the model must rely solely on sequence reasoning and general biological knowledge.
- The 'Antifungal biosynthesis' pathway label is a UniProt-specific categorization; in broader biochemical taxonomy this might fall under 'secondary metabolite biosynthesis' or 'natural product biosynthesis.'

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "One can reasonably infer from the long multi-modular architecture (~1358 aa) with recognizable adenylation and condensation domain motifs that this is a nonribosomal peptide synthetase (NRPS), which effectively eliminates option A (cell wall degradation, typically glycosyl hydrolases) and option B (ubiquinone biosynthesis, typically prenyltransferases and oxidoreductases). However, NRPS enzymes produce both antifungal compounds and pigments, so the sequence alone does not distinguish option C from option D.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Knowing that this specific NRPS (rstn8) produces restricticin, a CYP51 inhibitor with antifungal activity, rather than a pigment compound, requires knowledge of the specific biosynthetic gene cluster context and the biological activity of the final product—information not derivable from the amino acid sequence alone.",
    "reason": "While NRPS identification eliminates A and B through general domain-architecture reasoning, the distinction between 'antifungal biosynthesis' (C) and 'pigment biosynthesis' (D) depends on knowing the specific compound produced and its biological activity, which is an item-specific fact absent from the sequence input."
  },
  "case_id": "pathway_0179",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A0L1JF11 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:33857369. The protein is a nonribosomal peptide synthetase (rstn8) in the restricticin biosynthesis gene cluster of Aspergillus nomiae, and restricticin is a natural product CYP51 inhibitor with antifungal activity. The sequence match is confirmed (SHA256 identical)."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries experimental evidence (ECO:0000269) from a 2021 JACS paper characterizing the restricticin BGC, so the key is well-supported by primary literature.",
    "The protein was first publicly annotated in UniProt on 2025-02-05; if the benchmark was constructed before that date, the annotation may have come from a different source or been inferred computationally.",
    "The reviewer-only evidence was absent from the evaluated model input; the model must rely solely on sequence reasoning and general biological knowledge.",
    "The 'Antifungal biosynthesis' pathway label is a UniProt-specific categorization; in broader biochemical taxonomy this might fall under 'secondary metabolite biosynthesis' or 'natural product biosynthesis.'"
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "C",
      "D"
    ],
    "reason": "Both antifungal biosynthesis and pigment biosynthesis are common NRPS-derived pathways in fungi. Without the gene cluster context or knowledge of the specific product (restricticin), a model identifying the protein as an NRPS could plausibly select either C or D. The UniProt annotation resolves this to C, but the sequence alone does not."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0179",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A0L1JF11 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:33857369. The protein is a nonribosomal peptide synthetase (rstn8) in the restricticin biosynthesis gene cluster of Aspergillus nomiae, and restricticin is a natural product CYP51 inhibitor with antifungal activity. The sequence match is confirmed (SHA256 identical).",
    "evidence_ids": ["C5", "C4", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "One can reasonably infer from the long multi-modular architecture (~1358 aa) with recognizable adenylation and condensation domain motifs that this is a nonribosomal peptide synthetase (NRPS), which effectively eliminates option A (cell wall degradation, typically glycosyl hydrolases) and option B (ubiquinone biosynthesis, typically prenyltransferases and oxidoreductases). However, NRPS enzymes produce both antifungal compounds and pigments, so the sequence alone does not distinguish option C from option D.",
    "missing_item_specific_fact": "Knowing that this specific NRPS (rstn8) produces restricticin, a CYP51 inhibitor with antifungal activity, rather than a pigment compound, requires knowledge of the specific biosynthetic gene cluster context and the biological activity of the final product—information not derivable from the amino acid sequence alone.",
    "reason": "While NRPS identification eliminates A and B through general domain-architecture reasoning, the distinction between 'antifungal biosynthesis' (C) and 'pigment biosynthesis' (D) depends on knowing the specific compound produced and its biological activity, which is an item-specific fact absent from the sequence input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["C", "D"],
    "reason": "Both antifungal biosynthesis and pigment biosynthesis are common NRPS-derived pathways in fungi. Without the gene cluster context or knowledge of the specific product (restricticin), a model identifying the protein as an NRPS could plausibly select either C or D. The UniProt annotation resolves this to C, but the sequence alone does not."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries experimental evidence (ECO:0000269) from a 2021 JACS paper characterizing the restricticin BGC, so the key is well-supported by primary literature.",
    "The protein was first publicly annotated in UniProt on 2025-02-05; if the benchmark was constructed before that date, the annotation may have come from a different source or been inferred computationally.",
    "The reviewer-only evidence was absent from the evaluated model input; the model must rely solely on sequence reasoning and general biological knowledge.",
    "The 'Antifungal biosynthesis' pathway label is a UniProt-specific categorization; in broader biochemical taxonomy this might fall under 'secondary metabolite biosynthesis' or 'natural product biosynthesis.'"
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record assigns the protein to antifungal biosynthesis and cites experimental evidence (ECO:0000269), supporting the key. This is a database annotation citing a publication, not an independent review of that study.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The long sequence has the modular architecture characteristic of a fungal nonribosomal peptide synthetase, including repeated catalytic and carrier-domain features. NRPSs commonly assemble bioactive secondary metabolites; among these choices, antifungal biosynthesis is a better fit than cell-wall degradation or ubiquinone biosynthesis. Fungal pigments are often made by polyketide synthases, so the NRPS architecture also favors C over D, though it does not identify the specific product.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Transferable knowledge of NRPS architecture and fungal secondary metabolism provides a meaningful, probabilistic basis for selecting C from these alternatives. The sequence alone does not establish the product's antifungal activity, so the inference is less decisive than the reviewer-only annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The NRPS architecture supports a secondary-metabolite role, and the offered alternatives make antifungal biosynthesis the best fit. It does not prove the exact pathway, but the available alternatives are not equally supported.


### Important caveats

- The sequence-based inference does not by itself establish the specific metabolite or its antifungal activity.
- The pathway annotation is supported by a cited publication, but that study was not independently evaluated here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence has the modular architecture characteristic of a fungal nonribosomal peptide synthetase, including repeated catalytic and carrier-domain features. NRPSs commonly assemble bioactive secondary metabolites; among these choices, antifungal biosynthesis is a better fit than cell-wall degradation or ubiquinone biosynthesis. Fungal pigments are often made by polyketide synthases, so the NRPS architecture also favors C over D, though it does not identify the specific product.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Transferable knowledge of NRPS architecture and fungal secondary metabolism provides a meaningful, probabilistic basis for selecting C from these alternatives. The sequence alone does not establish the product's antifungal activity, so the inference is less decisive than the reviewer-only annotation."
  },
  "case_id": "pathway_0179",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record assigns the protein to antifungal biosynthesis and cites experimental evidence (ECO:0000269), supporting the key. This is a database annotation citing a publication, not an independent review of that study."
  },
  "important_caveats": [
    "The sequence-based inference does not by itself establish the specific metabolite or its antifungal activity.",
    "The pathway annotation is supported by a cited publication, but that study was not independently evaluated here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The NRPS architecture supports a secondary-metabolite role, and the offered alternatives make antifungal biosynthesis the best fit. It does not prove the exact pathway, but the available alternatives are not equally supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0179",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record assigns the protein to antifungal biosynthesis and cites experimental evidence (ECO:0000269), supporting the key. This is a database annotation citing a publication, not an independent review of that study.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The long sequence has the modular architecture characteristic of a fungal nonribosomal peptide synthetase, including repeated catalytic and carrier-domain features. NRPSs commonly assemble bioactive secondary metabolites; among these choices, antifungal biosynthesis is a better fit than cell-wall degradation or ubiquinone biosynthesis. Fungal pigments are often made by polyketide synthases, so the NRPS architecture also favors C over D, though it does not identify the specific product.",
    "missing_item_specific_fact": "",
    "reason": "Transferable knowledge of NRPS architecture and fungal secondary metabolism provides a meaningful, probabilistic basis for selecting C from these alternatives. The sequence alone does not establish the product's antifungal activity, so the inference is less decisive than the reviewer-only annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The NRPS architecture supports a secondary-metabolite role, and the offered alternatives make antifungal biosynthesis the best fit. It does not prove the exact pathway, but the available alternatives are not equally supported."
  },
  "important_caveats": [
    "The sequence-based inference does not by itself establish the specific metabolite or its antifungal activity.",
    "The pathway annotation is supported by a cited publication, but that study was not independently evaluated here."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** output error.
**Canonical saved status:** `invalid_review`.

**This saved response has an output error and is not a usable structured review.** Any labels below remain the original saved values; they are excluded from label distributions and agreement. This output status does not judge the benchmark question, author key or biological correctness. No field or option ID has been repaired.

No visible final review text was saved. Internal model reasoning is not a substitute for a visible review and is not published. The final-content extraction failed because the saved final content was not text.

**Saved parsed visible review:** `null`.

**Exact saved visible final text:** empty string (`""`). No visible final is synthesized from private reasoning.

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A0L1JF11",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "37c310372aac1c1a3260d3d2dd7bacf07caf7bbf6f4d21e869d8f2f966c024b1",
  "benchmark_sequence_length": 1358,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 43,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2015-11-11",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "current_source_sequence_sha256": "37c310372aac1c1a3260d3d2dd7bacf07caf7bbf6f4d21e869d8f2f966c024b1",
  "current_source_sequence_length": 1358,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 41,
  "selected_historical_version": {
    "accession": "A0A0L1JF11",
    "database": "Swiss-Prot",
    "entryVersion": 41,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RSTN8_ASPN3",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "d90784deda82bb78af24fa1babc1da69e6ef26f5a77034ba845f02029dbced6d",
  "selected_historical_source_sequence_sha256": "37c310372aac1c1a3260d3d2dd7bacf07caf7bbf6f4d21e869d8f2f966c024b1",
  "selected_historical_source_sequence_length": 1358,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 41,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json",
  "source_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "retrieved_utc": "2026-11-01T06:24:40.345446+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A0L1JF11\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json",
  "source_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "retrieved_utc": "2026-11-01T06:24:40.345446+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":43,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2015-11-11\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json",
  "source_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "retrieved_utc": "2026-11-01T06:24:40.345446+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93)\",\"taxonId\":1509407}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json",
  "source_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "retrieved_utc": "2026-11-01T06:24:40.345446+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein 8\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"6.3.2.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Nonribosomal peptide synthetase rstn8\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json",
  "source_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "retrieved_utc": "2026-11-01T06:24:40.345446+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF11.json",
  "source_sha256": "c4747f7695d004ff8ea5a8c179d271c3d96bfd468ffd19f64a22f32b7d7896f2",
  "retrieved_utc": "2026-11-01T06:24:40.345446+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF11?format=txt&versions=41)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF11?format=txt&versions=41",
  "source_sha256": "d90784deda82bb78af24fa1babc1da69e6ef26f5a77034ba845f02029dbced6d",
  "retrieved_utc": "2026-11-01T06:27:19.711233+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   RSTN8_ASPN3             Reviewed;        1358 AA.\nAC   A0A0L1JF11;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   11-NOV-2015, sequence version 1.\nDT   28-JAN-2026, entry version 41.\nDE   RecName: Full=Nonribosomal peptide synthetase rstn8 {ECO:0000303|PubMed:33857369};\nDE            EC=6.3.2.- {ECO:0000269|PubMed:33857369};\nDE   AltName: Full=Restricticin biosynthesis cluster protein 8 {ECO:0000303|PubMed:33857369};\nGN   Name=rstn8 {ECO:0000303|PubMed:33857369}; ORFNames=ANOM_001447;\nOS   Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 /\nOS   M93).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=1509407;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 41,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF11?format=txt&versions=41)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF11?format=txt&versions=41",
  "source_sha256": "d90784deda82bb78af24fa1babc1da69e6ef26f5a77034ba845f02029dbced6d",
  "retrieved_utc": "2026-11-01T06:27:19.711233+00:00",
  "source_locator": "lines 24-31",
  "excerpt": "RN   [2]\nRP   FUNCTION, AND PATHWAY.\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 41,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF11?format=txt&versions=41)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF11?format=txt&versions=41",
  "source_sha256": "d90784deda82bb78af24fa1babc1da69e6ef26f5a77034ba845f02029dbced6d",
  "retrieved_utc": "2026-11-01T06:27:19.711233+00:00",
  "source_locator": "lines 65-65",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 41,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 179. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
